|
1
|
A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
|
Eur Urol
|
2010
|
7.70
|
|
2
|
Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.
|
Eur Urol
|
2012
|
4.08
|
|
3
|
A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
|
Eur Urol
|
2006
|
2.80
|
|
4
|
Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial.
|
Eur Urol
|
2006
|
2.38
|
|
5
|
Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG.
|
Eur Urol
|
2013
|
2.02
|
|
6
|
Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution.
|
Pediatrics
|
2005
|
1.99
|
|
7
|
2005 update on pathology of prostate biopsies with cancer.
|
Eur Urol
|
2006
|
1.66
|
|
8
|
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
|
Cancer Res
|
2003
|
1.60
|
|
9
|
Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993).
|
Eur Urol
|
2010
|
1.52
|
|
10
|
Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT.
|
J Invest Dermatol
|
2009
|
1.48
|
|
11
|
Handling and pathology reporting of prostate biopsies.
|
Eur Urol
|
2004
|
1.11
|
|
12
|
In vivo characterization of melanin in melanocytic lesions: spectroscopic study on 1671 pigmented skin lesions.
|
J Biomed Opt
|
2009
|
1.08
|
|
13
|
Distribution of melanoma on breast surface suggests its etiology.
|
Int J Cancer
|
2003
|
0.85
|
|
14
|
In vivo evaluation of melanoma thickness by multispectral imaging and an artificial neural network. A retrospective study on 250 cases of cutaneous melanoma.
|
Tumori
|
2007
|
0.84
|
|
15
|
Automated melanoma detection with a novel multispectral imaging system: results of a prospective study.
|
Phys Med Biol
|
2005
|
0.84
|
|
16
|
Molecular prostate cancer pathology: current issues and achievements.
|
Scand J Urol Nephrol Suppl
|
2005
|
0.79
|
|
17
|
Automated melanoma detection: multispectral imaging and neural network approach for classification.
|
Med Phys
|
2003
|
0.76
|
|
18
|
Pigmented spindle-cell nevus: a melanoma simulator.
|
Dermatol Online J
|
2004
|
0.75
|
|
19
|
Automated segmentation of pigmented skin lesions in multispectral imaging.
|
Phys Med Biol
|
2005
|
0.75
|
|
20
|
Early diagnosis remains the most reliable way to cure children with melanoma.
|
Pediatr Blood Cancer
|
2005
|
0.75
|